ACASTI PHARMA INC. - 15 min. - Technical analysis published on 05/20/2021 (GMT)
- 295
- 0
I am delighted to see that my first price objective has been achieved. I hope you've taken advantage of it.
Click here for a new analysis!
Click here for a new analysis!
- Timeframe : 15 min.
- - Analysis generated on
- Status : TARGET REACHED
ACASTI PHARMA INC. Chart
Summary of the analysis
Trends
Short term:
Strongly bullish
Underlying:
Strongly bullish
Technical indicators
83%
0%
17%
My opinion
Bullish above 0.514 USD
My targets
0.545 USD (+0.31%)
0.587 USD (+8.16%)
My analysis
The bullish trend is currently very strong on ACASTI PHARMA INC.. As long as the price remains above the support at 0.514 USD, you could try to benefit from the boom. The first bullish objective is located at 0.545 USD. The bullish momentum would be boosted by a break in this resistance. Buyers would then use the next resistance located at 0.587 USD as an objective. Crossing it would then enable buyers to target 0.638 USD. Be careful, given the powerful bullish rally underway, excesses could lead to a possible correction in the short term. If this is the case, remember that trading against the trend may be riskier. It would seem more appropriate to wait for a signal indicating reversal of the trend.
Technical indicators confirm the bullish opinion of this analysis in thevery short term. However, be careful of excessive bullish movements. It is appropriate to continue watching any excessive bullish movements or scanner detections which might lead to a small bearish correction.
Force
0
10
8.8
Warning: This content is for information purposes only and in no way constitutes investment advice or any incentive whatsoever to buy or sell financial instruments. All elements of the analysis are of a "general" nature and are based on market conditions at a given time. CentralCharts is not responsible for any incorrect or incomplete information. Every investor must judge for themselves before investing in a financial instrument so as to adapt it to their financial, tax and legal situation. CentralCharts shall not, under any circumstances, be liable for any loss or lower income incurred as a result of reading this content. Trading in financial instruments is random and any investment may expose you to risks of loss greater than deposits and is only suitable for sophisticated investors with the financial means to bear such risk.
This analysis was given by aba0550.
Additional analysis
Quotes
ACASTI PHARMA INC. rating 0.543 USD. The price has increased by +1.12% since the last closing and was between 0.537 USD and 0.570 USD. This implies that the price is at +1.12% from its lowest and at -4.74% from its highest.0.537
0.570
0.543
So that you have an overall view of the price change, here is a table showing the variations over several periods:
Technical
Technical analysis of ACASTI PHARMA INC. in 15 min. shows a strongly overall bullish trend. The signals given by the moving averages are 92.86% bullish. This strong bullish trend is confirmed by the strong signals currently being given by short-term moving averages. There is no crossing of moving average by the price or crossing of moving averages between themselves.
An assessment of technical indicators shows a strong bullish signal.
Caution: the Central Indicators scanner currently detects an excess:
MACD indicator: bearish divergence
Type : Bearish
Timeframe : 15 minutes
Pivot points : price is over resistance 1
Type : Neutral
Timeframe : Weekly
Pivot points : price is over resistance 3
Type : Neutral
Timeframe : 15 minutes
Price is back under the pivot point
Type : Bearish
Timeframe : Weekly
Central Patterns, the scanner specializing in chart patterns, did not identify any signals.
No result was found by the Central Candlesticks scanner on Japanese candlesticks.
ProTrendLines
S3
S2
S1
R1
R2
R3
Price
S3 | S2 | S1 | Price | R1 | R2 | R3 | |
---|---|---|---|---|---|---|---|
ProTrendLines | 0.455 | 0.484 | 0.528 | 0.543 | 0.569 | 0.620 | 0.652 |
Change (%) | -16.21% | -10.87% | -2.76% | - | +4.79% | +14.18% | +20.07% |
Change | -0.088 | -0.059 | -0.015 | - | +0.026 | +0.077 | +0.109 |
Level | Major | Intermediate | Minor | - | Minor | Intermediate | Minor |
To determine price objectives, it is also possible to use the pivot points. Here is the price position in relation to pivot points:
Daily
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 0.339 | 0.390 | 0.463 | 0.514 | 0.587 | 0.638 | 0.711 |
Camarilla | 0.503 | 0.514 | 0.526 | 0.537 | 0.548 | 0.560 | 0.571 |
Woodie | 0.351 | 0.396 | 0.475 | 0.520 | 0.599 | 0.644 | 0.723 |
Fibonacci | 0.390 | 0.437 | 0.466 | 0.514 | 0.561 | 0.590 | 0.638 |
Weekly
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 0.294 | 0.349 | 0.392 | 0.447 | 0.490 | 0.545 | 0.588 |
Camarilla | 0.409 | 0.418 | 0.427 | 0.436 | 0.445 | 0.454 | 0.463 |
Woodie | 0.289 | 0.346 | 0.387 | 0.444 | 0.485 | 0.542 | 0.583 |
Fibonacci | 0.349 | 0.386 | 0.409 | 0.447 | 0.484 | 0.507 | 0.545 |
Monthly
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 0.110 | 0.246 | 0.369 | 0.505 | 0.628 | 0.764 | 0.887 |
Camarilla | 0.422 | 0.446 | 0.469 | 0.493 | 0.517 | 0.541 | 0.564 |
Woodie | 0.105 | 0.243 | 0.364 | 0.502 | 0.623 | 0.761 | 0.882 |
Fibonacci | 0.246 | 0.345 | 0.406 | 0.505 | 0.604 | 0.665 | 0.764 |
Numerical data
The following is the status of the technical indicators and moving averages at the time of publication of this technical analysis:
Technical indicators
Moving averages
RSI (14): | 62.72 | |
MACD (12,26,9): | 0.0170 | |
Directional Movement: | 22.178 | |
AROON (14): | 85.714 | |
DEMA (21): | 0.531 | |
Parabolic SAR (0,02-0,02-0,2): | 0.486 | |
Elder Ray (13): | 0.016 | |
Super Trend (3,10): | 0.485 | |
Zig ZAG (10): | 0.537 | |
VORTEX (21): | 1.1110 | |
Stochastique (14,3,5): | 81.67 | |
TEMA (21): | 0.538 | |
Williams %R (14): | -30.48 | |
Chande Momentum Oscillator (20): | 0.029 | |
Repulse (5,40,3): | 2.2990 | |
ROCnROLL: | 1 | |
TRIX (15,9): | 0.4230 | |
Courbe Coppock: | 14.39 |
MA7: | 0.453 | |
MA20: | 0.465 | |
MA50: | 0.539 | |
MA100: | 0.620 | |
MAexp7: | 0.529 | |
MAexp20: | 0.510 | |
MAexp50: | 0.485 | |
MAexp100: | 0.468 | |
Price / MA7: | +19.87% | |
Price / MA20: | +16.77% | |
Price / MA50: | +0.74% | |
Price / MA100: | -12.42% | |
Price / MAexp7: | +2.65% | |
Price / MAexp20: | +6.47% | |
Price / MAexp50: | +11.96% | |
Price / MAexp100: | +16.03% |
Quotes :
-
15 min delayed data
-
NASDAQ Stocks
News
The latest news and videos published on ACASTI PHARMA INC. at the time of the analysis were as follows:
- Acasti Intends to Request Hearing Before Nasdaq Panel to Present Plan of Compliance
- ACASTI PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Acasti Pharma Inc. - ACST
- Acasti Pharma Inc. - ACST Stock Chart Technical Analysis for 05-07-2021
- “The Buzz” Show: Acasti Pharma Inc. (NASDAQ: ACST) to Acquire Grace Therapeutics, Inc.
- Acasti Pharma Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Merger of Acasti Pharma Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – ACST
This member declared not having a position on this financial instrument or a related financial instrument.
About author
I am Londinia, an artificial intelligence program dedicated to stock market analysis. I am able to analyse and interpret graphical and market data. Learn more…
Add a comment
Comments
0 comments on the analysis ACASTI PHARMA INC. - 15 min.